Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).
about
Activity of Sorafenib against desmoid tumor/deep fibromatosisMultiple desmoid tumors in a patient with Gardner's syndrome - Report of a caseA prognostic nomogram for prediction of recurrence in desmoid fibromatosis.A systematic review of active treatment options in patients with desmoid tumoursTreatment and follow-up strategies in desmoid tumours: a practice guideline.Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.Desmoid tumors: clinical features and treatment options for advanced diseaseSignal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptorsSignal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report.Neuropathic Pain due to Fibromatosis: Does Anticancer Treatment Help?Chest wall fibromatosis in the axillaSafety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.Dramatic and delayed response to Doxorubicin-dacarbazine chemotherapy of a giant desmoid tumor: case report and literature reviewResection and Abdominal Wall Reconstruction of a Desmoid Tumor with Endometrioma Features.The Role of Radiotherapy in the Treatment of Primary or Recurrent Desmoid Tumors and Long-Term Results.Desmoid tumors in the pediatric populationGastrointestinal Mesenchymal Neoplasms other than Gastrointestinal Stromal Tumors: Focusing on Their Molecular Aspects.Multimodality Management of Soft Tissue Tumors in the ExtremityPazopanib, a promising option for the treatment of aggressive fibromatosis.Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicin.Effect of surgical margins on prognosis in aggressive fibromatosis: A single-institutional analysis of 90 patients.Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment.Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.
P2860
Q24620775-D2E52084-47C8-4966-88C0-7145A954D2D3Q33781424-CAE3C39A-59D9-4397-BD2E-C3BDBCE77123Q33894889-EDBE0A16-8C9E-4B82-A301-412FFC4103D2Q33982743-8DC4A0BE-8EA7-4057-ACCD-7694BBE480F2Q33982758-08054159-F871-435A-BD78-817DC2423860Q34039279-37E8B9A3-10CD-4EBD-B653-1CF59F8A25BFQ34577487-F8C7F816-5DF5-4A4F-8E11-58F6D2ECDA5FQ34628337-71FFAAC1-1651-4E2F-9350-E17607FDA01FQ34643472-FF2F30B0-42FE-4602-9558-9131BBD9187CQ34782409-8722DA44-5D1F-46C8-B056-24E7D4E45D8BQ35016339-D26E563F-2A78-453C-97B0-E46B1D28ACB6Q35748871-6557E71A-6C50-4A16-8363-C89BD53878AEQ36064474-C2247E68-62B2-43EC-9459-3BBE77406CC2Q36283018-FB5586E7-507B-4ACE-AF34-3DE2057458B5Q36744322-1EA0AB97-1FFA-43E6-ADA8-3D213A0A58B9Q36928171-E7BF772A-708B-4288-B64C-ED759D9F3A68Q36983717-91C90DCD-E627-4B58-8987-5F47C44FD80AQ37016966-CF840062-4ECA-474E-853D-5AFD9ADED382Q37853030-8D35EC21-C703-4387-9DF9-2225BA88DFB1Q38932249-FF015381-147A-4BDA-B7BC-AFFC507C7FADQ42204905-01F2AC8C-F0CA-4157-BDAC-9E767C36D633Q42425711-9A635968-835E-4766-9461-E10B63BF6100Q45543441-7EEDE6D2-D9FC-42EB-941A-65038CA85DF6Q48243797-E3E36659-519C-4537-B8BC-E35E7B720EFAQ50003156-F2DBB7D9-E726-4AFD-9D3F-204EB29B8839Q55052699-5027A76D-9329-406A-ACA6-9B852DBB35F0
P2860
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@ast
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@en
Clinical outcomes of systemic therapy for patients with deep fibromatosis
@nl
type
label
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@ast
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@en
Clinical outcomes of systemic therapy for patients with deep fibromatosis
@nl
prefLabel
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@ast
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@en
Clinical outcomes of systemic therapy for patients with deep fibromatosis
@nl
P2093
P2860
P356
P1433
P1476
Clinical outcomes of systemic ...... fibromatosis (desmoid tumor).
@en
P2093
Cristina R Antonescu
David R D'Adamo
Linda S Ahn
Mary L Keohan
Robert G Maki
Samuel Singer
Veridiana Pires de Camargo
P2860
P304
P356
10.1002/CNCR.25089
P407
P577
2010-05-01T00:00:00Z